Global and United States Alzheimer's Disease Diagnostic Market Report & Forecast 2024-2031

Report ID: 1844086 | Published Date: Oct 2024 | No. of Page: 86 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
1 Study Coverage
    1.1 Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Alzheimer's Disease Diagnostic Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Alzheimer's Disease Diagnostic Market Size for the Year 2017-2028
        1.2.2 Global Alzheimer's Disease Diagnostic Market Size for the Year 2017-2028
    1.3 Alzheimer's Disease Diagnostic Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Alzheimer's Disease Diagnostic in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Alzheimer's Disease Diagnostic Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Alzheimer's Disease Diagnostic Market Dynamics
        1.4.1 Alzheimer's Disease Diagnostic Industry Trends
        1.4.2 Alzheimer's Disease Diagnostic Market Drivers
        1.4.3 Alzheimer's Disease Diagnostic Market Challenges
        1.4.4 Alzheimer's Disease Diagnostic Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Alzheimer's Disease Diagnostic by Type
    2.1 Alzheimer's Disease Diagnostic Market Segment by Type
        2.1.1 Genetic Testing
        2.1.2 Neurological Exam
        2.1.3 Mini-Mental State Exam(MMSE)
        2.1.4 Brain Imaging
        2.1.5 Other
    2.2 Global Alzheimer's Disease Diagnostic Market Size by Type (2017, 2022 & 2028)
    2.3 Global Alzheimer's Disease Diagnostic Market Size by Type (2017-2028)
    2.4 United States Alzheimer's Disease Diagnostic Market Size by Type (2017, 2022 & 2028)
    2.5 United States Alzheimer's Disease Diagnostic Market Size by Type (2017-2028)
3 Alzheimer's Disease Diagnostic by Application
    3.1 Alzheimer's Disease Diagnostic Market Segment by Application
        3.1.1 Clinics
        3.1.2 Hospitals
        3.1.3 Diagnostic Centers
        3.1.4 Other
    3.2 Global Alzheimer's Disease Diagnostic Market Size by Application (2017, 2022 & 2028)
    3.3 Global Alzheimer's Disease Diagnostic Market Size by Application (2017-2028)
    3.4 United States Alzheimer's Disease Diagnostic Market Size by Application (2017, 2022 & 2028)
    3.5 United States Alzheimer's Disease Diagnostic Market Size by Application (2017-2028)
4 Global Alzheimer's Disease Diagnostic Competitor Landscape by Company
    4.1 Global Alzheimer's Disease Diagnostic Market Size by Company
        4.1.1 Top Global Alzheimer's Disease Diagnostic Companies Ranked by Revenue (2021)
        4.1.2 Global Alzheimer's Disease Diagnostic Revenue by Player (2017-2022)
    4.2 Global Alzheimer's Disease Diagnostic Concentration Ratio (CR)
        4.2.1 Alzheimer's Disease Diagnostic Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Alzheimer's Disease Diagnostic in 2021
        4.2.3 Global Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Alzheimer's Disease Diagnostic Headquarters, Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Alzheimer's Disease Diagnostic Headquarters and Area Served
        4.3.2 Global Alzheimer's Disease Diagnostic Companies Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Alzheimer's Disease Diagnostic Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Alzheimer's Disease Diagnostic Market Size by Company
        4.5.1 Top Alzheimer's Disease Diagnostic Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Alzheimer's Disease Diagnostic Revenue by Players (2020, 2021 & 2022)
5 Global Alzheimer's Disease Diagnostic Market Size by Region
    5.1 Global Alzheimer's Disease Diagnostic Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Alzheimer's Disease Diagnostic Market Size by Region (2017-2028)
        5.2.1 Global Alzheimer's Disease Diagnostic Market Size by Region: 2017-2022
        5.2.2 Global Alzheimer's Disease Diagnostic Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Alzheimer's Disease Diagnostic Market Size YoY Growth 2017-2028
        6.1.2 North America Alzheimer's Disease Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Alzheimer's Disease Diagnostic Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Alzheimer's Disease Diagnostic Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Alzheimer's Disease Diagnostic Market Size YoY Growth 2017-2028
        6.3.2 Europe Alzheimer's Disease Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Alzheimer's Disease Diagnostic Market Size YoY Growth 2017-2028
        6.4.2 Latin America Alzheimer's Disease Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Alzheimer's Disease Diagnostic Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Alzheimer's Disease Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Eli Lilly
        7.1.1 Eli Lilly Company Details
        7.1.2 Eli Lilly Business Overview
        7.1.3 Eli Lilly Alzheimer's Disease Diagnostic Introduction
        7.1.4 Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
        7.1.5 Eli Lilly Recent Development
    7.2 TauRx
        7.2.1 TauRx Company Details
        7.2.2 TauRx Business Overview
        7.2.3 TauRx Alzheimer's Disease Diagnostic Introduction
        7.2.4 TauRx Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
        7.2.5 TauRx Recent Development
    7.3 Alector
        7.3.1 Alector Company Details
        7.3.2 Alector Business Overview
        7.3.3 Alector Alzheimer's Disease Diagnostic Introduction
        7.3.4 Alector Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
        7.3.5 Alector Recent Development
    7.4 Accera
        7.4.1 Accera Company Details
        7.4.2 Accera Business Overview
        7.4.3 Accera Alzheimer's Disease Diagnostic Introduction
        7.4.4 Accera Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
        7.4.5 Accera Recent Development
    7.5 Treventis
        7.5.1 Treventis Company Details
        7.5.2 Treventis Business Overview
        7.5.3 Treventis Alzheimer's Disease Diagnostic Introduction
        7.5.4 Treventis Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
        7.5.5 Treventis Recent Development
    7.6 Neuro-Bio
        7.6.1 Neuro-Bio Company Details
        7.6.2 Neuro-Bio Business Overview
        7.6.3 Neuro-Bio Alzheimer's Disease Diagnostic Introduction
        7.6.4 Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
        7.6.5 Neuro-Bio Recent Development
    7.7 Cognition Therapeutics
        7.7.1 Cognition Therapeutics Company Details
        7.7.2 Cognition Therapeutics Business Overview
        7.7.3 Cognition Therapeutics Alzheimer's Disease Diagnostic Introduction
        7.7.4 Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
        7.7.5 Cognition Therapeutics Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. Alzheimer's Disease Diagnostic Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Alzheimer's Disease Diagnostic Market Trends
    Table 3. Alzheimer's Disease Diagnostic Market Drivers
    Table 4. Alzheimer's Disease Diagnostic Market Challenges
    Table 5. Alzheimer's Disease Diagnostic Market Restraints
    Table 6. Global Alzheimer's Disease Diagnostic Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Alzheimer's Disease Diagnostic Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Alzheimer's Disease Diagnostic Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Alzheimer's Disease Diagnostic Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Alzheimer's Disease Diagnostic Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Alzheimer's Disease Diagnostic Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Alzheimer's Disease Diagnostic Revenue Share by Player, 2017-2022
    Table 13. Global Alzheimer's Disease Diagnostic Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Alzheimer's Disease Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2021)
    Table 15. Top Players of Alzheimer's Disease Diagnostic in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Alzheimer's Disease Diagnostic Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Alzheimer's Disease Diagnostic Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Alzheimer's Disease Diagnostic Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Alzheimer's Disease Diagnostic Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Alzheimer's Disease Diagnostic Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Alzheimer's Disease Diagnostic Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Alzheimer's Disease Diagnostic Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Alzheimer's Disease Diagnostic Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Alzheimer's Disease Diagnostic Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Alzheimer's Disease Diagnostic Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Alzheimer's Disease Diagnostic Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Alzheimer's Disease Diagnostic Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Eli Lilly Company Details
    Table 31. Eli Lilly Business Overview
    Table 32. Eli Lilly Alzheimer's Disease Diagnostic Product
    Table 33. Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 34. Eli Lilly Recent Development
    Table 35. TauRx Company Details
    Table 36. TauRx Business Overview
    Table 37. TauRx Alzheimer's Disease Diagnostic Product
    Table 38. TauRx Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 39. TauRx Recent Development
    Table 40. Alector Company Details
    Table 41. Alector Business Overview
    Table 42. Alector Alzheimer's Disease Diagnostic Product
    Table 43. Alector Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 44. Alector Recent Development
    Table 45. Accera Company Details
    Table 46. Accera Business Overview
    Table 47. Accera Alzheimer's Disease Diagnostic Product
    Table 48. Accera Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 49. Accera Recent Development
    Table 50. Treventis Company Details
    Table 51. Treventis Business Overview
    Table 52. Treventis Alzheimer's Disease Diagnostic Product
    Table 53. Treventis Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 54. Treventis Recent Development
    Table 55. Neuro-Bio Company Details
    Table 56. Neuro-Bio Business Overview
    Table 57. Neuro-Bio Alzheimer's Disease Diagnostic Product
    Table 58. Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 59. Neuro-Bio Recent Development
    Table 60. Cognition Therapeutics Company Details
    Table 61. Cognition Therapeutics Business Overview
    Table 62. Cognition Therapeutics Alzheimer's Disease Diagnostic Product
    Table 63. Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 64. Cognition Therapeutics Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Alzheimer's Disease Diagnostic Product Picture
    Figure 2. Global Alzheimer's Disease Diagnostic Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Alzheimer's Disease Diagnostic Market Size 2017-2028 (US$ Million)
    Figure 4. United States Alzheimer's Disease Diagnostic Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Alzheimer's Disease Diagnostic Market Size 2017-2028 (US$ Million)
    Figure 6. United States Alzheimer's Disease Diagnostic Market Share in Global 2017-2028
    Figure 7. Alzheimer's Disease Diagnostic Report Years Considered
    Figure 8. Product Picture of Genetic Testing
    Figure 9. Product Picture of Neurological Exam
    Figure 10. Product Picture of Mini-Mental State Exam(MMSE)
    Figure 11. Product Picture of Brain Imaging
    Figure 12. Product Picture of Other
    Figure 13. Global Alzheimer's Disease Diagnostic Market Share by Type in 2022 & 2028
    Figure 14. Global Alzheimer's Disease Diagnostic Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global Alzheimer's Disease Diagnostic Market Share by Type (2017-2028)
    Figure 16. United States Alzheimer's Disease Diagnostic Market Share by Type in 2022 & 2028
    Figure 17. United States Alzheimer's Disease Diagnostic Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States Alzheimer's Disease Diagnostic Market Share by Type (2017-2028)
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Hospitals
    Figure 21. Product Picture of Diagnostic Centers
    Figure 22. Product Picture of Other
    Figure 23. Global Alzheimer's Disease Diagnostic Market Share by Application in 2022 & 2028
    Figure 24. Global Alzheimer's Disease Diagnostic Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Alzheimer's Disease Diagnostic Market Share by Application (2017-2028)
    Figure 26. United States Alzheimer's Disease Diagnostic Market Share by Application in 2022 & 2028
    Figure 27. United States Alzheimer's Disease Diagnostic Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Alzheimer's Disease Diagnostic Market Share by Application (2017-2028)
    Figure 29. North America Alzheimer's Disease Diagnostic Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Alzheimer's Disease Diagnostic Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Alzheimer's Disease Diagnostic Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Alzheimer's Disease Diagnostic Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Alzheimer's Disease Diagnostic Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E Alzheimer's Disease Diagnostic Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Eli Lilly Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 58. TauRx Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 59. Alector Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 60. Accera Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 61. Treventis Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 62. Neuro-Bio Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 63. Cognition Therapeutics Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
TauRx
Alector
Accera
Treventis
Neuro-Bio
Cognition Therapeutics
Frequently Asked Questions
Alzheimer's Disease Diagnostic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alzheimer's Disease Diagnostic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alzheimer's Disease Diagnostic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Amblyopia

Amblyopia market is segmented by region (country), players, by Type and by Application. Players,  ... Read More

Anal Cancer

Anal Cancer market is segmented by region (country), players, by Type and by Application. Players ... Read More